LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

1246P Hybrid capture-based assays in primary diagnostics of NSCLC patients: Results from the NEOlung study

Photo by mdominguezfoto from unsplash

1NEO New Oncology GmbH, Cologne, Germany, 2University of Berne and Cantonal Hospital of Lucerne, Switzerland, 3Department of Pneumology, Clinic Schillerhoehe, Gerlingen, Germany, 4Institut du Thorax Curie-Montsouris, Institut Curie, Paris, France,… Click to show full abstract

1NEO New Oncology GmbH, Cologne, Germany, 2University of Berne and Cantonal Hospital of Lucerne, Switzerland, 3Department of Pneumology, Clinic Schillerhoehe, Gerlingen, Germany, 4Institut du Thorax Curie-Montsouris, Institut Curie, Paris, France, 5Asklepios Lung Clinic, Munich-Gauting, Germany, 6Medical Oncology Department, Hospital Ramón y Cajal, Madrid, Spain, 7Department of Oncology & Hematology, AUSL Romagna, Ravenna, Italy, 8Cancer Clinical Trials Unit, University College Hospitals, London, United Kingdom, 9Evangelische Lungenklinik Berlin, Berlin, Germany, 10Department of Hematology and Oncology, University Hospital of Mannheim, Mannheim, Germany, 11Thoraxonkologie, Asklepios Klinikum, Hamburg, Germany, 12Oncology, Pfizer Pharma GmbH, Berlin, Germany, 13Lung Cancer Network, NOWEL, Oldenburg, Germany, 14Hematology and Oncology, Pius Hospital, University of Oldenburg, Oldenburg, Germany

Keywords: hematology; hospital; capture based; hybrid capture; 1246p hybrid; oncology

Journal Title: Annals of Oncology
Year Published: 2020

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.